These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

335 related items for PubMed ID: 1096755

  • 21. [Study of crystalluria as a method of evaluation of preventive medical treatment of renal calculosis].
    Buli P, Pulini V, Platania A, Petrone U, Brunocilla E, Martorelli M.
    Minerva Urol; 1982; 34(3):137-50. PubMed ID: 7177065
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Pyridoxine therapy in patients with renal calcium oxalate calculi.
    Balcke P, Schmidt P, Zazgornik J, Kopsa H, Minar E.
    Proc Eur Dial Transplant Assoc; 1983; 20():417-21. PubMed ID: 6657665
    [Abstract] [Full Text] [Related]

  • 27. Magnesium oxide-pyridoxine therapy for recurrent urolithiasis.
    Nutr Rev; 1976 Jan; 34(1):18-20. PubMed ID: 765895
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Oxalosis].
    Broyer M, Berger R.
    Presse Med (1893); 1968 Dec 21; 76(50):2395-6. PubMed ID: 5732646
    [No Abstract] [Full Text] [Related]

  • 30. Effect of hyperprotidic diet associated or not with hypercalcic diet on calcium oxalate stone formation in rat.
    Sakly R, Bardaoui M, Neffati F, Moussa A, Zakhama A, Najjar MF, Hammami M.
    Ann Nutr Metab; 2005 Dec 21; 49(2):132-8. PubMed ID: 15860912
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Calcium oxalate crystalluria and urine saturation in recurrent renal stone-formers.
    Robertson WG, Peacock M, Nordin BE.
    Clin Sci; 1971 May 21; 40(5):365-74. PubMed ID: 5556093
    [No Abstract] [Full Text] [Related]

  • 38. [Mechanisms of renal lithogenesis. (VIII) Therapeutic response of hyperoxaluric patients after 5 years' treatment].
    Ruiz-Marcellán FJ, Bernshtam J, Pinto B.
    Rev Clin Esp; 1983 Jan 15; 168(1):9-12. PubMed ID: 6844687
    [No Abstract] [Full Text] [Related]

  • 39. Urine composition in patients with renal stone disease during treatment with allopurinol.
    Tiselius HG, Larsson L.
    Scand J Urol Nephrol; 1980 Jan 15; 14(1):65-71. PubMed ID: 7375845
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.